Literature DB >> 20204850

An efficient approach to the production of vaccines against the malaria parasite.

Takafumi Tsuboi1, Satoru Takeo, Tatsuya Sawasaki, Motomi Torii, Yaeta Endo.   

Abstract

In malaria vaccine research, one of the major obstacles has been the difficulty of expressing recombinant malarial proteins and it is mainly due to the lack of an efficient methodology for the synthesis of sufficient quantity of quality proteins. We demonstrate that the wheat germ cell-free protein synthesis system can be applied for the successful production of leading malaria vaccine candidate antigens and, thus, prove that it may be a key tool for malaria vaccine research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204850     DOI: 10.1007/978-1-60327-331-2_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  25 in total

1.  Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.

Authors:  Yang Cheng; Bo Wang; Jetsumon Sattabongkot; Chae Seung Lim; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2014-04-25       Impact factor: 2.289

2.  RALP1 is a rhoptry neck erythrocyte-binding protein of Plasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigen.

Authors:  Daisuke Ito; Tomoyuki Hasegawa; Kazutoyo Miura; Tsutomu Yamasaki; Thangavelu U Arumugam; Amporn Thongkukiatkul; Satoru Takeo; Eizo Takashima; Jetsumon Sattabongkot; Eun-Taek Han; Carole A Long; Motomi Torii; Takafumi Tsuboi
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

3.  N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity.

Authors:  Mayumi Tachibana; Yimin Wu; Hideyuki Iriko; Olga Muratova; Nicholas J MacDonald; Jetsumon Sattabongkot; Satoru Takeo; Hitoshi Otsuki; Motomi Torii; Takafumi Tsuboi
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

4.  HeLa Based Cell Free Expression Systems for Expression of Plasmodium Rhoptry Proteins.

Authors:  Raghavendra Yadavalli; Tobili Sam-Yellowe
Journal:  J Vis Exp       Date:  2015-06-10       Impact factor: 1.355

5.  A densely overlapping gene fragmentation approach improves yeast two-hybrid screens for Plasmodium falciparum proteins.

Authors:  Hakeenah F Brown; Ling Wang; Sudip Khadka; Stanley Fields; Douglas J LaCount
Journal:  Mol Biochem Parasitol       Date:  2011-04-20       Impact factor: 1.759

6.  Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.

Authors:  Kailash P Patra; Fengwu Li; Darrick Carter; James A Gregory; Sheyenne Baga; Steven G Reed; Stephen P Mayfield; Joseph M Vinetz
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

7.  In vitro human cell-free expression system for synthesis of malaria proteins.

Authors:  R Yadavalli; C Ledger; T Y Sam-Yellowe
Journal:  Parasitol Res       Date:  2012-07-11       Impact factor: 2.289

8.  Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax.

Authors:  Bo Wang; Feng Lu; Yang Cheng; Jian Li; Daisuke Ito; Jetsumon Sattabongkot; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2012-10-25       Impact factor: 2.289

9.  Single-Molecule Fluorescence Detection of the Epidermal Growth Factor Receptor in Membrane Discs.

Authors:  Steven D Quinn; Shwetha Srinivasan; Jesse B Gordon; Wei He; Kermit L Carraway; Matthew A Coleman; Gabriela S Schlau-Cohen
Journal:  Biochemistry       Date:  2018-04-06       Impact factor: 3.162

10.  The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax.

Authors:  Yang Cheng; Yue Wang; Daisuke Ito; Deok-Hoon Kong; Kwon-Soo Ha; Jun-Hu Chen; Feng Lu; Jian Li; Bo Wang; Eizo Takashima; Jetsumon Sattabongkot; Takafumi Tsuboi; Eun-Taek Han
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.